Results 241 to 250 of about 101,568 (272)
Some of the next articles are maybe not open access.
2006
Measles ranks fifth among the five major childhood conditions which are responsible for 21% of all deaths in low and middle-income countries. Measles immunization is considered the most cost-effective public health intervention in the world. In recent years, there has been a critical need to identify alternative routes of measles immunization, which ...
M. de Lourdes Garcia-Garcia +5 more
openaire +3 more sources
Measles ranks fifth among the five major childhood conditions which are responsible for 21% of all deaths in low and middle-income countries. Measles immunization is considered the most cost-effective public health intervention in the world. In recent years, there has been a critical need to identify alternative routes of measles immunization, which ...
M. de Lourdes Garcia-Garcia +5 more
openaire +3 more sources
Annals of Internal Medicine, 1990
Excerpt To the Editor:The need for adequate immunity to measles in international travelers, outlined by Hill and Pearson (1) and von Reyn and Saviteer (2), is clear cut.
openaire +3 more sources
Excerpt To the Editor:The need for adequate immunity to measles in international travelers, outlined by Hill and Pearson (1) and von Reyn and Saviteer (2), is clear cut.
openaire +3 more sources
Measles Vaccination in Infants
JAMA: The Journal of the American Medical Association, 1982To the Editor.— On May 15, 1981, the Centers for Disease Control (CDC) reported an outbreak of measles among the children of migrant farm workers in Texas. Among these were 42 infants younger than 15 months. The CDC and the Office of Migrant Health recommended that "infants ages 6 months through 14 months be vaccinated." 1 In June of this year a ...
openaire +3 more sources
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2021Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Nature Reviews Clinical Oncology, 2021Aakash Desai +2 more
exaly

